Skip to main content
. 2022 Apr 22;11:e76100. doi: 10.7554/eLife.76100

Figure 5. Backside mutant impairs K48 chain binding.

(A) Deuterium uptake plots showing how the F117A mutation affects hydrogen-deuterium exchange in a peptide corresponding to residues 115–125 located in the α5–6 motif of UCH37. For comparison, the uptake plots corresponding to a region located outside the α5–6 motif (residues 200–218) are also shown. The data on the top represents the rate of exchange with UCH37C88A•RPN13DEUBAD and the data on the bottom corresponds to UCH37C88A/F117A•RPN13DEUBAD. At least two replicates of each experiment were performed. (B)1H13C-methyl TROSY NMR spectra of the Ile region of ILV-labeled K48 di-ubiquitin (Ub) proximal subunit (Ubprox) free in solution (gray) and bound to UCH37C88A•RPN13DEUBAD (the C88A complex; green). Ratio of UCH37 to K48 di-Ub is 1:1.5. Concentrations used: 45 μM UCH37C88A•RPN13DEUBAD and 30 μM K48 di-Ub. (C)1H13C-methyl TROSY NMR spectra of the Ile region of ILV-labeled K48 di-Ub distal subunit (Ubdist) free in solution (gray) and bound to the C88A complex (orange). Ratio of UCH37 to K48 di-Ub is 1:1.5. Concentrations used: 45 μM UCH37C88A •RPN13DEUBAD and 30 μM K48 di-Ub. (D) 1H13C-methyl TROSY NMR spectra of the Ile region of K48-linked Ubprox free in solution (gray) and bound to UCH37C88A/F117A•RPN13DEUBAD (the F117A complex; green). Ratio of UCH37 to K48 di-Ub is 1:1.5. Concentrations used: 45 μM UCH37C88A/F117A•RPN13DEUBAD and 30 μM K48 di-Ub. (E)1H13C-methyl TROSY NMR spectra of the Ile region of K48-linked Ubdist free in solution (gray) and bound to the F117A complex (orange). Ratio of UCH37 to K48 di-Ub is 1:1.5. Concentrations used: 45 μM UCH37C88A/F117A•RPN13DEUBAD and 30 μM K48 di-Ub. (F)1H13C-methyl TROSY NMR spectra of the Ile region of mono-Ub bound to the C88A complex (orange) and the F117A complex (blue). Ratio of UCH37 to mono-Ub is 1:1.5. Concentrations used: 45 μM UCH37 •RPN13DEUBAD complex and 30 μM mono-Ub.

Figure 5—source data 1. Full NMR spectra of mono-Ub and K48 di-Ub in presence and absence of UCH37.

Figure 5.

Figure 5—figure supplement 1. Backside mutant impairs K48 chain binding.

Figure 5—figure supplement 1.

(A) Isothermal titration calorimetry (ITC) analyses of mono-ubiquitin (Ub) and K48 di-Ub binding to UCH37C88A/F117A•RPN13. (B) ITC analyses of mono-Ub and K48 di-Ub binding to UCH37C88A/F121A•RPN13. (C) Hydrolysis of Ub-AMC by the indicated UCH37 variants. Each variant is in complex with RPN13. (D) Table of binding affinities for different UCH37 variants measured by ITC. (E) ITC analyses of mono-Ub and K48 di-Ub binding to UCH37C88A/L181A•RPN13. (F) Surface representation of UCH37 colored by conservation.